Jane M. Lynch

Jane Lynch practices at Shenandoah Dermatology in Staunton, Virginia.

Jane Lynch's NPI, 1952370553, was assigned on March 16, 2006. Jane Lynch holds Virginia license 0101-228437.

Jane Lynch's primary practice is Shenandoah Dermatology, at 1600 N Coalter St Suite 19 Suite 19, Staunton, VA 24401-2566. The practice phone is (540) 885-4500.

Jane Lynch's primary practice is Shenandoah Dermatology in Staunton, Virginia. Jane Lynch is also affiliated with Sentara RMH Medical Center. The medical group on file is Shenandoah Dermatology & Aesthetics. Dmand AI also links Jane Lynch to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jane Lynch practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Jane Lynch's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Jane Lynch is licensed in Virginia.

CMS data shows 6,868 Medicare services from Jane Lynch across 22 procedure codes in 2024, for 928 Medicare patients. Medicare paid $223,276 for them. Every service was in an office.

CMS counts 928 Medicare patients who saw Jane Lynch in 2024. The largest group is 65 to 74, with 445 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jane Lynch's median patient age at 65, with 62% women.

In 2024, Jane Lynch wrote 2,017 Medicare Part D claims for 554 patients. 89% of them were for generic drugs. CMS names the drug for 1,826 of them, across 26 drugs with 11 or more claims each, at $621,384 in total drug cost. In 2023, CMS named 1,427 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Jane Lynch for performance year 2024, reported as part of a group. Jane Lynch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,498 procedures of removal of skin lesions by Jane Lynch, more than 96% of the clinicians it reports for that procedure.

CMS Open Payments shows 130 general payments to Jane Lynch from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $579. It also lists 4 research payments totaling $8,918 in 2023.